Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0134 | 0.376 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0134 | 0.376 | 0.5 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0134 | 0.376 | 0.679 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0593 | 0.1073 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.5528 | 1 |
Echinococcus granulosus | caspase 8 | 0.0134 | 0.376 | 0.3746 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0048 | 0.0593 | 0.0573 |
Echinococcus granulosus | caspase 2 | 0.0182 | 0.5528 | 0.5518 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.0048 | 0.0593 | 0.0573 |
Echinococcus granulosus | caspase | 0.0304 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Trypanosoma brucei | metacaspase MCA2 | 0.0134 | 0.376 | 0.5 |
Onchocerca volvulus | 0.0048 | 0.0593 | 0.1038 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0134 | 0.376 | 0.5 |
Plasmodium falciparum | metacaspase 1 | 0.0134 | 0.376 | 0.5 |
Leishmania major | metacaspase, putative | 0.0134 | 0.376 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.0134 | 0.376 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0022 | 0.004 |
Trypanosoma cruzi | metacaspase, putative | 0.0134 | 0.376 | 0.5 |
Echinococcus multilocularis | caspase 3 | 0.017 | 0.5066 | 0.5055 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0134 | 0.376 | 0.5 |
Plasmodium falciparum | metacaspase-like protein | 0.0134 | 0.376 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0182 | 0.5528 | 0.5518 |
Trypanosoma brucei | metacaspase 5, putative | 0.0134 | 0.376 | 0.5 |
Echinococcus multilocularis | caspase 2 | 0.0182 | 0.5528 | 0.5518 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0134 | 0.376 | 0.3746 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0134 | 0.376 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.0134 | 0.376 | 0.5 |
Plasmodium vivax | metacaspase 1, putative | 0.0134 | 0.376 | 0.5 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0134 | 0.376 | 0.5 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0304 | 1 | 1 |
Echinococcus granulosus | caspase 3 | 0.017 | 0.5066 | 0.5055 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0182 | 0.5528 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0134 | 0.376 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Echinococcus multilocularis | caspase | 0.0304 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0134 | 0.376 | 0.5 |
Trypanosoma brucei | metacaspase | 0.0134 | 0.376 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0022 | 0.004 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0134 | 0.376 | 0.5 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0304 | 1 | 1 |
Trypanosoma brucei | Metacaspase-4 | 0.0134 | 0.376 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Brugia malayi | Cell death protein 3 precursor | 0.0182 | 0.5528 | 1 |
Echinococcus multilocularis | caspase 8 | 0.0134 | 0.376 | 0.3746 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0304 | 1 | 1 |
Trypanosoma brucei | metacaspase MCA3 | 0.0134 | 0.376 | 0.5 |
Brugia malayi | hypothetical protein | 0.0048 | 0.0593 | 0.1038 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0134 | 0.376 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0022 | 0.004 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0134 | 0.376 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.376 | 0.6802 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Trypanosoma cruzi | metacaspase, putative | 0.0134 | 0.376 | 0.5 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0134 | 0.376 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0593 | 0.0573 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0134 | 0.376 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Saccharomyces cerevisiae | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.